Mannkind Corporation
Clinical trials sponsored by Mannkind Corporation, explained in plain language.
-
New inhaled powder tested for scarred lungs
Disease control Recruiting nowThis early-stage study is testing the safety and how the body processes a new inhaled powder version of a drug called nintedanib in people with idiopathic pulmonary fibrosis (IPF), a serious lung-scarring disease. The trial will enroll about 24 patients to see if inhaling the dru…
Phase: PHASE1 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Kids with new diabetes try inhaled insulin in new study
Disease control Recruiting nowThis study is testing whether an inhaled insulin called Afrezza, used with a daily long-acting insulin shot, is safe and effective for controlling blood sugar in young people (ages 10-18) who were just diagnosed with type 1 diabetes. It will measure how well the treatment keeps b…
Phase: PHASE2 • Sponsor: Mannkind Corporation • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC